Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sildenafil vs Viagra in Healthy Males
NCT04882826Phase 1Unknown
- Sponsor
- Pharmtechnology
- Start
- May 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ASP-001 in erectile dysfunction (ED) (2 arms), sponsored by Pharmtechnology. Primary endpoints: Maximum Plasma Concentration at 24.00 hours and Area Under the Curve to the Last Quantifiable Concentration at 24.00 hours. Status: unknown.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04882826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882826.